Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
CHESHIRE, Conn., Sept. 2 /PRNewswire-FirstCall/ -- Alexion
Pharmaceuticals, Inc. (Nasdaq: ALXN stock)...
CHESHIRE, Conn., March 20 /PRNewswire-FirstCall/ -- Alexion
Pharmaceuticals, Inc. (the 'Company') (Nasdaq: ALXN) today announced that it
has completed enrolling patients in its previously...
CHESHIRE, Conn., Nov. 9 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that data relating to paroxysmal nocturnal hemoglobinuria (PNH), as well as...
CHICAGO--(BUSINESS WIRE)--William Blair & Company initiated research coverage of Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) ($36.29) with an Outperform rating. Alexion’s...